Emma C. Troisi

662 total citations
6 papers, 419 citations indexed

About

Emma C. Troisi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Emma C. Troisi has authored 6 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Genetics. Recurrent topics in Emma C. Troisi's work include Cancer Mechanisms and Therapy (3 papers), Chromatin Remodeling and Cancer (3 papers) and Glioma Diagnosis and Treatment (2 papers). Emma C. Troisi is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Chromatin Remodeling and Cancer (3 papers) and Glioma Diagnosis and Treatment (2 papers). Emma C. Troisi collaborates with scholars based in United States. Emma C. Troisi's co-authors include Su Wang, Jeffrey R. Haswell, Xiaofeng Wang, Peter J. Park, Charles W.M. Roberts, Evgeni P. Tzvetkov, Jaclyn A. Biegel, Jakub Mieczkowski, Yotam Drier and Shawn Gillespie and has published in prestigious journals such as Nature Communications, Nature Genetics and Cancer Research.

In The Last Decade

Emma C. Troisi

5 papers receiving 416 citations

Peers

Emma C. Troisi

MB

PFM

IMMUN

ONCOL

PRM

Valentina Fragliasso Italy

Iwona K. Rzepecka Poland

María García‐Álvarez Spain

Valentina Agnusdei Italy

Stefanie Bug Germany

Jan Konrad Siwicki Poland

Esther Tijchon Netherlands

Stavros Giannakopoulos United States

Michaël Porcu Belgium

David Martin‐García Spain

Valentina Fragliasso Italy

Emma C. Troisi

176 ×0.5

MB

41 ×0.2

PFM

41 ×0.7

IMMUN

74 ×1.9

ONCOL

29 ×1.0

PRM

Citations per year, relative to Emma C. Troisi Emma C. Troisi (= 1×) peers Valentina Fragliasso

Countries citing papers authored by Emma C. Troisi

Since Specialization

Citations

This map shows the geographic impact of Emma C. Troisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma C. Troisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma C. Troisi more than expected).

Fields of papers citing papers by Emma C. Troisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma C. Troisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma C. Troisi. The network helps show where Emma C. Troisi may publish in the future.

Co-authorship network of co-authors of Emma C. Troisi

This figure shows the co-authorship network connecting the top 25 collaborators of Emma C. Troisi. A scholar is included among the top collaborators of Emma C. Troisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma C. Troisi. Emma C. Troisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Troisi, Emma C., et al.. (2022). Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma. Nature Communications. 13(1). 3936–3936. 13 indexed citations

2.

Govek, Kiya W., et al.. (2021). Single-cell transcriptomic analysis of mIHC images via antigen mapping. Science Advances. 7(10). 29 indexed citations

3.

Troisi, Emma C., et al.. (2021). EPEN-06. CELL ECOSYSTEM AND SIGNALING PATHWAYS OF PRIMARY AND METASTATIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMA. Neuro-Oncology. 23(Supplement_1). i14–i14.

4.

Wang, Xiaofeng, Su Wang, Emma C. Troisi, et al.. (2019). BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors. Nature Communications. 10(1). 1881–1881. 137 indexed citations

5.

Wang, Xiaofeng, Ryan Lee, B. Alver, et al.. (2017). Abstract LB-096: SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Cancer Research. 77(13_Supplement). LB–96. 1 indexed citations

6.

Wang, Xiaofeng, Ryan S. Lee, B. Alver, et al.. (2016). SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics. 49(2). 289–295. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact